BRIDGETTE MARCOTTE: Open Payments
NPI 1578964714 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 41 payments from 11 companies in 2025. Trend: 2023 $658 · 2024 $1,005 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $353 |
| KYOWA KIRIN, INC. | 1 | $130 |
| Axsome Therapeutics, Inc. | 6 | $96 |
| Novo Nordisk Inc | 4 | $73 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Amgen Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: QULIPTA, UBRELVY, Auvelity, REXULTI, Wegovy, CAPLYTA, VRAYLAR, BREZTRI.
Industry payments across LA — which companies pay providers there.
